Longitudinal analysis of National Institutes of Health funding for academic thoracic surgeons.

Longitudinal analysis of National Institutes of Health funding for academic thoracic surgeons.
复制标题

DOI:
10.1016/j.jtcvs.2021.01.088
复制
发表时间:
2022-03
期刊:
The Journal of thoracic and cardiovascular surgery
影响因子:
--
通讯作者:
Ailawadi G
Ailawadi G
中科院分区:
其他
文献类型:
--
作者:
Narahari AK;Mehaffey JH;Chandrabhatla AS;Hawkins RB;Charles EJ;Roeser ME;Lau C;Ailawadi G

文献摘要

参考文献

相似文献

National Institutes of Health (NIH) funding for academic (non-cardiac) thoracic surgeons at the top 140 NIH-funded institutes in the United States was assessed. We hypothesized that thoracic surgeons have difficulty in obtaining NIH funding in a difficult funding climate. The top 140 NIH-funded institutes’ faculty pages were searched for non-cardiac thoracic surgeons. Surgeon data including gender, academic rank, and post-fellowship training were recorded. These surgeons were then queried in NIH Research Portfolio Online Reporting Tools Expenditures and Results (NIH RePORTER) for their funding history. Analysis of the resulting grants (1980–2019) included grant type, funding amount, project start/end dates, publications, and a citation-based Grant Impact Metric to evaluate productivity. A total of 395 general thoracic surgeons were evaluated with 63 (16%) receiving NIH funding. These 63 surgeons received 136 grants totaling $228 million, resulting in 1,772 publications, and generating over 50,000 citations. Thoracic surgeons have obtained NIH funding at an increasing rate (1980 – 2019); however, they have a low percentage of R01 renewal (17.3%). NIH-funded thoracic surgeons were more likely to have a higher professorship level. Thoracic surgeons perform similarly to other physician-scientists in converting K-Awards into R01 funding. Contrary to our hypothesis, thoracic surgeons have received more NIH funding over time. Thoracic surgeons are able to fill the roles of modern surgeon-scientists by obtaining NIH funding during an era of increasing clinical demands. The NIH should continue to support this mission.
DOI: 10.1016/j.jamcollsurg.2017.12.047
发表时间: 2018-04-01
影响因子: 5.2
作者:
Narahari, Adishesh K.;Mehaffey, J. Hunter;Ailawadi, Gorav
通讯作者: Ailawadi, Gorav
DOI: 10.1016/j.jtcvs.2018.12.104
发表时间: 2019-08
期刊: The Journal of thoracic and cardiovascular surgery
影响因子: --
作者:
Sterbling HM;Molena D;Rao SR;Stein SL;Litle VR
通讯作者: Litle VR
DOI: 10.1016/j.jtcvs.2017.12.041
发表时间: 2018-05-01
影响因子: 6
作者:
Narahari, Adishesh K.;Charles, Eric J.;Kron, Irving L.
通讯作者: Kron, Irving L.
DOI: 10.1161/circresaha.114.302656
发表时间: 2014-02-14
影响因子: 20.1
作者:
Danthi N;Wu CO;Shi P;Lauer M
通讯作者: Lauer M
DOI: 10.1016/j.jtcvs.2019.08.032
发表时间: 2020-06
期刊: The Journal of thoracic and cardiovascular surgery
影响因子: --
作者:
Narahari AK;Cook IO;Mehaffey JH;Chandrabhatla AS;Hawkins RB;Tyerman Z;Charles EJ;Tribble CG;Kron IL;Teman NR;Roeser ME;Ailawadi G
通讯作者: Ailawadi G